Myself as a concentrated investor, I am disturbingly overweight CU6 (ignoring gain). I go drunkenmiller - hard and dump afterwards if need be - call me pigsy. Hence I haven't bought much on the way up. (I seek to be a long term investor.)
I suspect @Davisite may be a concentrated investor as well. (We are well aware of the Kelly criterion.) So here is an interesting graph on diversification and non-market risk. Risk% can propell portfolio in both directions.
Let's say non-income earning companies with low bank balances carry a lot more risk, and especially during mkt turbulance. Therefore CU6 is positioned well in this regard.
I certainly don't advocate concentrated investing for beginners - Let your education be well diversified with small $amounts. Don't get suckered into the "Lambo club" one stock punter club. Infact concentrated investing probably isn't the majority style at all. BTW Having few stocks because of time constraints is not concentrated investing.
DYODD Not investment advice.
- Forums
- ASX - By Stock
- CU6
- Ann: Clarity launches $121 million equity raise
Ann: Clarity launches $121 million equity raise, page-63
-
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
(20min delay)
|
|||||
Last
$7.46 |
Change
-0.020(0.27%) |
Mkt cap ! $2.388B |
Open | High | Low | Value | Volume |
$7.33 | $7.60 | $7.30 | $5.064M | 675.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2776 | $7.44 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.49 | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2776 | 7.440 |
2 | 3056 | 7.430 |
1 | 2776 | 7.420 |
3 | 16988 | 7.410 |
1 | 1104 | 7.400 |
Price($) | Vol. | No. |
---|---|---|
7.490 | 5000 | 1 |
7.510 | 5000 | 1 |
7.520 | 3056 | 2 |
7.540 | 2776 | 1 |
7.550 | 15864 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online